Withdrawal of Wydase, Hyaluronidase Injection
🏛 Food and Drug Administration (FDA)FDA-2003-P-0406
Documents
2
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
📄 Primary document
OtherNov 12, 2003
Letter from FDA CDER to Amphastar Pharmaceuticals, Inc.- Other· Jul 25, 2003